Ascentage Pharma Group International (AAPG) Intangibles (2022 - 2025)

Ascentage Pharma Group International (AAPG) has 4 years of Intangibles data on file, last reported at $9.3 million in Q4 2025.

• For the quarter ending Q4 2025, Intangibles fell 12.13% year-over-year to $9.3 million; the trailing twelve-month figure through Dec 2025 stood at $9.3 million (down 12.13% YoY), and the FY2025 full-year result was $9.4 million, down 9.44% from the prior year.
• Intangibles for Q4 2025 stood at $9.3 million, down from $9.9 million in the prior quarter.
• Across five years, Intangibles topped out at $10.6 million in Q4 2024 and bottomed at $4.0 million in Q4 2022.
• The 4-year median for Intangibles is $9.3 million (2025), against an average of $8.1 million.
• The widest annual swing landed in 2023, when Intangibles surged 65.95%; it then slipped 12.13% in 2025.
• A 4-year view of Intangibles shows it stood at $4.0 million in 2022, then soared by 65.95% to $6.7 million in 2023, then surged by 58.41% to $10.6 million in 2024, then declined by 12.13% to $9.3 million in 2025.
• The last three Intangibles figures came in at $9.3 million (Q4 2025), $9.9 million (Q2 2025), and $10.6 million (Q4 2024), per Business Quant data.

Peer Comparison